ARTICLE | Company News
Tm Bioscience diagnostic news
November 20, 2006 8:00 AM UTC
TMC said it will explore strategic alternatives including the sale or merger of the company. TMC has retained Leerink Swann and Westwind Partners as financial advisors. TMC has a Cystic fibrosis (CF) ...